Anti-ELOVL6 monoclonal antibody

Pre-made anti-ELOVL6 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ELOVL6/ELOVL6 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0750-Ab-1/ GM-Tg-hg-IP0750-Ab-2Anti-Human ELOVL6 monoclonal antibodyHuman
GM-Tg-rg-IP0750-Ab-1/ GM-Tg-rg-IP0750-Ab-2Anti-Rat ELOVL6 monoclonal antibodyRat
GM-Tg-mg-IP0750-Ab-1/ GM-Tg-mg-IP0750-Ab-2Anti-Mouse ELOVL6 monoclonal antibodyMouse
GM-Tg-cynog-IP0750-Ab-1/ GM-Tg-cynog-IP0750-Ab-2Anti-Cynomolgus/ Rhesus macaque ELOVL6 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0750-Ab-1/ GM-Tg-felg-IP0750-Ab-2Anti-Feline ELOVL6 monoclonal antibodyFeline
GM-Tg-cang-IP0750-Ab-1/ GM-Tg-cang-IP0750-Ab-2Anti-Canine ELOVL6 monoclonal antibodyCanine
GM-Tg-bovg-IP0750-Ab-1/ GM-Tg-bovg-IP0750-Ab-2Anti-Bovine ELOVL6 monoclonal antibodyBovine
GM-Tg-equg-IP0750-Ab-1/ GM-Tg-equg-IP0750-Ab-2Anti-Equine ELOVL6 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0750-Ab-1/ GM-Tg-hg-IP0750-Ab-2; GM-Tg-rg-IP0750-Ab-1/ GM-Tg-rg-IP0750-Ab-2;
GM-Tg-mg-IP0750-Ab-1/ GM-Tg-mg-IP0750-Ab-2; GM-Tg-cynog-IP0750-Ab-1/ GM-Tg-cynog-IP0750-Ab-2;
GM-Tg-felg-IP0750-Ab-1/ GM-Tg-felg-IP0750-Ab-2; GM-Tg-cang-IP0750-Ab-1/ GM-Tg-cang-IP0750-Ab-2;
GM-Tg-bovg-IP0750-Ab-1/ GM-Tg-bovg-IP0750-Ab-2; GM-Tg-equg-IP0750-Ab-1/ GM-Tg-equg-IP0750-Ab-2
Products NameAnti-ELOVL6 monoclonal antibody
Formatmab
Target NameELOVL6
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ELOVL6 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0750-Ag-1Recombinant multi-species ELOV6/ ELOVL6/ FACE protein
    ORF Viral VectorvGMLP000904human ELOVL6 Lentivirus particle
    ORF Viral VectorpGMLP000904human ELOVL6 Lentivirus plasmid
    ORF Viral VectorpGMLPm003715mouse Elovl6 Lentivirus plasmid
    ORF Viral VectorvGMLPm003715mouse Elovl6 Lentivirus particle


    Target information

    Target IDGM-IP0750
    Target NameELOVL6
    Gene ID79071,170439,171402,698870,487900,101082563,533333,100072829
    Gene Symbol and SynonymsELOVL6,FACE,FAE,hELO2,LCE,Lce2,rELO2
    Uniprot AccessionQ9H5J4,Q920L6
    Uniprot Entry NameELOV6_HUMAN,ELOV6_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000170522
    Target ClassificationN/A

    The target: ELOVL6, gene name: ELOVL6, also named as FACE, FAE, LCE. Fatty acid elongases (EC 6.2.1.3), such as ELOVL6, use malonyl-CoA as a 2-carbon donor in the first and rate-limiting step of fatty acid elongation (Moon et al., 2001 [PubMed 11567032]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.